Evidence map›Paper›PMID 28977439›Full record

ReviewHuman molecular genetics2017

The genomic landscape of African populations in health and disease.

Charles N Rotimi, Amy R Bentley, Ayo P Doumatey, Guanjie Chen, Daniel Shriner, Adebowale Adeyemo

Abstract readReview
In one paragraph

Review in Human molecular genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Bioinformatics proficiency among African students.Frontiers in bioinformatics · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Charles N RotimiCenter for Research on Genomics and Global Health, National Human Genome Research Institute, Bethesda, MD 20892, USA.
Amy R BentleyCenter for Research on Genomics and Global Health, National Human Genome Research Institute, Bethesda, MD 20892, USA.
Ayo P DoumateyCenter for Research on Genomics and Global Health, National Human Genome Research Institute, Bethesda, MD 20892, USA.
Guanjie ChenCenter for Research on Genomics and Global Health, National Human Genome Research Institute, Bethesda, MD 20892, USA.
Daniel ShrinerCenter for Research on Genomics and Global Health, National Human Genome Research Institute, Bethesda, MD 20892, USA.
Adebowale AdeyemoCenter for Research on Genomics and Global Health, National Human Genome Research Institute, Bethesda, MD 20892, USA.

Funding

Genetic epidemiology of complex diseasesZ01HG200362 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI ROTIMI, CHARLES · 2008 to 2008
$1.7M
Intramural NIH HHS Z01 HG200362NHGRI NIH HHS Z01HG200362
6 · The paper itself

Abstract

A deeper appreciation of the complex architecture of African genomes is critical to the global effort to understand human history, biology and differential distribution of disease by geography and ancestry. Here, we report on how the growing engagement of African populations in genome science is providing new insights into the forces that shaped human genomes before and after the Out-of-Africa migrations. As a result of this human evolutionary history, African ancestry populations have the greatest genomic diversity in the world, and this diversity has important ramifications for genomic research. In the case of pharmacogenomics, for instance, variants of consequence are not limited to those identified in other populations, and diversity within African ancestry populations precludes summarizing risk across different African ethnic groups. Exposure of Africans to fatal pathogens, such as Plasmodium falciparum, Lassa Virus and Trypanosoma brucei rhodesiense, has resulted in elevated frequencies of alleles conferring survival advantages for infectious diseases, but that are maladaptive in modern-day environments. Illustrating with cardiometabolic traits, we show that while genomic research in African ancestry populations is still in early stages, there are already many examples of novel and African ancestry-specific disease loci that have been discovered. Furthermore, the shorter haplotypes in African genomes have facilitated fine-mapping of loci discovered in other human ancestry populations. Given the insights already gained from the interrogation of African genomes, it is imperative to continue and increase our efforts to describe genomic risk in and across African ancestry populations.

Indexed as

AllelesBiological EvolutionBlack PeopleDiseaseGenetic Predisposition to DiseaseGenetics, PopulationGenetic VariationGenome, HumanGenomicsHaplotypesHealthHumansPharmacogeneticsPolymorphism, Single Nucleotide

Identifiers

PMID28977439
PMCPMC6075021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.